$4.75
7.7%
Price vs. AI Score (Last 150 days)
Data gathered: December 6
Data gathered: December 6
Data Bits
| Data Bits | Value / Change | Benchmark |
|---|---|---|
| Job Posts | 13 0% |
|
| Sentiment | 42 23.5% |
|
| Webpage traffic | 32,000 -14.4% |
|
| Employee Rating | 60 0% |
|
| Google Trends | -100% |
|
| Linkedin Employees | 760 N/A |
|
| Patents | 29 0% |
|
| 4chan Mentions | 0% | N/A |
| Facebook Engagement | 229 7.5% |
|
| Facebook followers | 1,714 0% |
|
| Stocktwits Mentions | 1 0% |
|
| Stocktwits Subscribers | 4,193 0% |
|
| Twitter Followers | 4,759 0% |
|
| Instagram Followers | 1,206 -0.1% |
|
| News Mentions | 0% |
|
| Reddit Mentions | 0% |
|
| Business outlook | 28 0% |
|
In the news
 |
Adaptive Biotechnologies and Collaborators to Present More than 30 Abstracts Demonstrating the Actionability of clonoSEQ® MRD Testing in Blood Cancer Patient Care and Drug Development at the 65th ASH Annual MeetingDecember 4 - Yahoo |
Adaptive, collaborators to present over 30 abstracts on clonoSEQ MRD testingDecember 4 - Thefly.com |
|
 |
Smart or AI In-Vitro Diagnostics Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce AnalyticNovember 29 - PR Newswire UK |
 |
Analyzing ARKG's Trading Activity In Q3November 22 - SeekingAlpha |
 |
Analysts Just Slashed Their Adaptive Biotechnologies Corporation (NASDAQ:ADPT) EPS NumbersNovember 16 - Yahoo |
Scotiabank Keeps Their Buy Rating on Adaptive Biotechnologies (ADPT)November 15 - TipRanks |
|
About Adaptive Biotechnologies
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases.
| Price | $4.75 |
| Target Price | Sign up |
| Market Cap | $644M |
| Dividend Yield | 0 |
| Industry | Biotechnology |
Similar companies
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | |
|---|---|---|---|---|---|
| Q3 '23 | 34M | 60M | -26M | -50M | -51M |
| Q2 '23 | 45M | 65M | -19M | -48M | -47M |
| Q1 '23 | 34M | 62M | -28M | -58M | -57M |
| Q4 '22 | 52M | 63M | -12M | -40M | -39M |
| Q3 '22 | 47M | 58M | -10M | -45M | -45M |
Insider Transactions
| PISKEL KYLE filed to sell 87,305 shares at $4.1. November 20 '23 |
| SOOD NITIN filed to sell 214,808 shares at $6.5. August 8 '23 |
| PETERSON TYCHO filed to sell 399,219 shares at $8.1. June 21 '23 |
| PETERSON TYCHO filed to sell 399,219 shares at $8.5. June 20 '23 |
| PETERSON TYCHO filed to sell 454,891 shares at $7.2. June 6 '23 |
Read more about Adaptive Biotechnologies and their earnings, price prediction, job posts, sentiment, webpage traffic, employee rating, google trends, linkedin employees, patents, 4chan mentions, facebook engagement, facebook followers, stocktwits mentions, stocktwits subscribers, twitter followers, instagram followers, news mentions, reddit mentions, business outlook.